Muthu V. Kumaran
Researcher
University of Arkansas for Medical Sciences
faculty
Research Areas
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
Muthu V. Kumaran's research focuses on outcomes and treatment efficacy for relapsed/refractory B-cell acute lymphoblastic leukemia (ALL), particularly in adult patient populations. Recent publications investigate the role of brexucabtagene autoleucel, exploring its efficacy and safety in older adults, and identifying factors such as NGS MRD negativity and KMT2Ar mutation status that impact progression-free survival and overall outcomes. Kumaran also examines the influence of social determinants of health on treatment responses in this patient group. Additionally, his work has touched upon outcomes of bronchoscopic lung volume reduction with endobronchial valves for advanced emphysema and the documentation of rare anatomical variations, such as an isolated systemic arterial supply to the upper lobe of the left lung.
Metrics
- h-index: 1
- Publications: 10
- Citations: 5
Selected Publications
- The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia (2025) DOI
- Efficacy and Safety of Brexucabtagene Autoleucel for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in Patients Aged 60 and Above (2024) DOI
- NGS MRD Negativity on Day 28 after Brexu Cel in Adults with R/R ALL Is Associated with Favorable Progression Free Survival (2024) DOI
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics